Anti-CCP

Also found in: Dictionary, Thesaurus, Medical, Encyclopedia.

Acronym	Definition
Anti-CCP	Antibodies against Cyclic Citrullinated Proteins

Suggest new definition

References in periodicals archive ?

Disease Durations, DAS 28 Scores, Anti-CCP, and RF Levels Group (n=40) Mean[+ or -]SD DAS28 3.52 [+ or -] 1.60 Disease duration, months 117.60 [+ or -] 65.79 n (%) Anti-CCP Negative 4 (10) Low-positive 5 (12.5) High-positive 31 (77.5) RF Negative 10 (25) Low-positive 15 (37.5) High-positive 15 (37.5) Group (n=40) p Mean[+ or -]SD DAS28 3.23[+ or -]0.996 0.348 Disease duration, months 146.1[+ or -]92.02 0.115 n (%) Anti-CCP Negative 6 (15) Low-positive 9 (22.5) 0.335 High-positive 25 (62.5) RF Negative 14 (35) Low-positive 10 (25) 0.428 High-positive 16 (40) DAS28: disease activity scores; Anti-CCP: anti-cyclic citrullinated peptide; RF: rheumatoid factor.

Effects of Conventional and Biological Drugs Used for the Treatment of Rheumatoid Arthritis on the Quality of Life and Depression

Recently, the ADVIA Centaur anti-CCP assay (Siemens Healthineers, Erlangen, Germany), which is based on a chemiluminescence immunoassay, has been developed and introduced to clinical laboratories.

Laboratory and Clinical Performance of the ADVIA Centaur Anticyclic Citrullinated Peptide Assay for Rheumatoid Arthritis Diagnosis

In a study conducted by Thabet MM and colleagues in 2008, they investigated the distribution of Fc[gamma]RIIIA 158V/F polymorphism in patients with anti-CCP positive RA.

INVESTIGATION OF THE FREQUENCY OF FC GAMMA RECEPTOR IIIA V/158/F GENE POLYMORPHISM AND COMPARISON OF CLINICAL AND LABORATORY FINDINGS IN RHEUMATOID ARTHRITIS (RA)/ROMATOiD ARTRiT'TE FC GAMA RESEPTOR IIIA V/158/F GEN POLiMORFiZMiNiN SIKLIGININ ARASTIRILMASI VE HASTA KLiNiK VE LABORATUAR BULGULARIYLA KARSILASTIRILMASI

Results: Mean anti-CCP level was 180.8 +- 290.3 Unit/ml.

Anti-Cyclic Citrullinated Peptide Antibody and Periodontal Status in Rheumatoid Arthritis Patients

Alone, RF or anti-CCP tests are not sufficient for the diagnosis of RA, because some patients have only one or the other biomarker, or lack both.

The importance of specificity in diagnostic tests for autoantibodies

Table 4 contains detailed information (anti-ARS antibody status, age, sex, MTX and bDMARDs treatments, anti-CCP, and RF values) for patients who tested positive for anti-ARS antibody and had also ILD.

The Association of Anti-Aminoacyl-Transfer Ribonucleic Acid Synthetase Antibodies in Patients With Rheumatoid Arthritis and Interstitial Lung Disease

Anti-CCP autoantibodies elicited the largest decrease in QUS index; however, these immune markers were not significantly associated with QUS index (r = -0.43; 95% CI: -1.51-0.65; p = 0.437).

A Cross-Sectional Study of the Association between Autoantibodies and Qualitative Ultrasound Index of Bone in an Elderly Sample without Clinical Autoimmune Disease

Seror and his colleagues demonstrated that elevated levels of Dkk-1 were associated with radiographic progression even after adjustment of known predictive factors of joint damage (erosions at baseline and anti-CCP positivity) [42].

Circulating Semaphorin 4D as a Marker for Predicting Radiographic Progression in Patients with Rheumatoid Arthritis

Laboratory tests revealed a normal blood count, an erythrocyte sedimentation rate of 56 mm/h, C-reactive protein of 2.36 mg/dL, rheumatoid factor of 84.1 IU/mL, and anti-CCP level of 63.2 U/mL.

Three Case Reports of Rhupus Syndrome: An Overlap Syndrome of Rheumatoid Arthritis and Systemic Lupus Erythematosus

Our case was also unique in that the positive anti-CCP antibody titre at both the time of diagnosis and during the follow-up suggests the possibility of rheumatoid arthritis (RA).

Amyopathic Dermatomyositis Associated with Histopathological Findings of Organizing Pneumonia and Pulmonary Vasculitis

The rheumatoid factor was 4 (normal 0 to 8), and anti-cyclic citrullinated peptide antibody (anti-CCP Ab) 135.9 (normal 0 to 20).

Rhupus syndrome: a case report

Objective: To study the erythrocyte sedimentation rate (ESR) and anti-cyclic citrullinated peptide (anti-CCP) antibodies in rheumatoid arthritis patients on disease modifying anti-rheumatic drug therapy.

STUDY OF ERYTHROCYTE SEDIMENTATION RATE AND ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODIES IN RHEUMATOID ARTHRITIS